Literature DB >> 15964528

[Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].

S Halioui-Louhaichi1, O Azzabi, L Nefzi, M Ben Hariz, N Ben Mrad, B Ben Ammar, A Maherzi.   

Abstract

UNLABELLED: Cushing's syndrome reveals McCune-Albright syndrome in a minority of patients. Bilateral adrenalectomy is performed on the majority of cases. CASE REPORT: We present a case of McCune-Albright syndrome revealed by a Cushing's syndrome treated by metyrapone. Results were good, after a 4-year follow up.
CONCLUSION: Treatment with metyrapone could be recommended, for some patients, in McCune-Albright syndrome with Cushing's syndrome before chirurgical treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964528     DOI: 10.1016/j.arcped.2005.03.044

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  3 in total

1.  Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia.

Authors:  Masanori Yoshida; Hiroshi Umeda; Shintaro Iwama; Seiko Nakayama; Misaki Miyata; Koichiro Ogawa; Harumi Maeda; Yutaka Oiso
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

2.  Rectal Metyrapone for Treatment of Hypercortisolism in an Infant with McCune-Albright Syndrome.

Authors:  Kate Verbeeten; Stasia Hadjiyannakis; Melody Cameron; Jaime McDonald
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

3.  Cushing syndrome in the McCune-Albright syndrome.

Authors:  Rebecca J Brown; Marilyn H Kelly; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2010-02-15       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.